Erratum: Magnesium supplementation affects metabolic status and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial (The American Journal of Clinical Nutrition (2015) 102:1 (222-229) DOI: 10.3945/ajcn.114.098616);Magnesium supplementation affects metabolic status and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial

American Journal of Clinical Nutrition

Volumn 102, Issue 1, 2015, Pages 222-229

  Asemi, Zatollah ^a   Karamali, Maryam ^b   Jamilian, Mehri ^b   Foroozanfard, Fatemeh ^a   Bahmani, Fereshteh ^a   Heidarzadeh, Zahra ^a   Benisi Kohansal, Sanaz ^d   Surkan, Pamela J ^c   Esmaillzadeh, Ahmad ^d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gestational diabetes; Magnesium; Pregnancy outcomes; Pregnant women; Supplementation

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MAGNESIUM OXIDE; MALONALDEHYDE; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; APGAR SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CESAREAN SECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYDRAMNIOS; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLISM; NEONATAL HYPERBILIRUBINEMIA; NEWBORN; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIABETES, GESTATIONAL; DIET RESTRICTION; DRUG EFFECTS; MAGNESIUM DEFICIENCY; OXIDATIVE STRESS; PREGNANCY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MAGNESIUM; MAGNESIUM DEFICIENCY; OXIDATIVE STRESS; PREGNANCY; PREGNANCY OUTCOME;

EID: 84937440837     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.1093/ajcn/nqaa320     Document Type: Erratum

References (63)

1. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011;25:37-49.
2. Nair AV, Hocher B, Verkaart S, van Zeeland F, Pfab T, Slowinski T, Chen YP, Schlingmann KP, Schaller A, Gallati S, et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci USA 2012;109:11324-9.
3. Volpe L, Di Cianni G, Lencioni C, Cuccuru I, Benzi L, Del Prato S. Gestational diabetes, inflammation, and late vascular disease. J Endocrinol Invest 2007;30:873-9.
4. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy-are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 2010;24:515-25.
5. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373:1789-97.
6. Nielsen KK, Kapur A, Damm P, de Courten M, Bygbjerg IC. From screening to postpartum follow-up-the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 2014;14:41.
7. Brewster S, Zinman B, Retnakaran R, Floras JS. Cardiometabolic consequences of gestational dysglycemia. J Am Coll Cardiol 2013;62: 677-84.
8. Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, Brand-Miller JC. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care 2011;34:2341-6.
9. Asemi Z, Samimi M, Tabassi Z, Sabihi SS, Esmaillzadeh A. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition 2013;29:619-24.
10. Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr 2013;98:1425-32.
11. Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial. Diabetologia 2014;57:1798-806.
12. Samimi M, Jamilian M, Asemi Z, Esmaillzadeh A. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: randomized, double-blind, placebo-controlled trial. Clin Nutr 2014 Jun 17 (Epub ahead of print; DOI: 10.1016/j.clnu.2014.06.005).
13. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS ONE 2013;8:e64585.
14. Del Gobbo LC, Song Y, Elin RJ, Meltzer SJ, Egeland GM. Gestational glucose intolerance modifies the association between magnesium and glycemic variables in mothers and daughters 15 years post-partum. Magnes Res 2012;25:54-63.
15. Bardicef M, Bardicef O, Sorokin Y, Altura BM, Altura BT, Resnick LM. Perinatal cellular ion metabolism: 31P-nuclear magnetic resonance spectroscopic analysis of intracellular free magnesium and pH in maternal and cord blood erythrocytes. J Soc Gynecol Investig 1996;3: 66-70.
16. Bullarbo M, Odman N, Nestler A, Nielsen T, Kolisek M, Vormann J, Rylander R. Magnesium supplementation to prevent high blood pressure in pregnancy: a randomised placebo control trial. Arch Gynecol Obstet 2013;288:1269-74.
17. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010;23:131-7.
18. Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebocontrolled trial. Arch Med Res 2014;45:388-93.
19. Moslehi N, Vafa M, Rahimi-Foroushani A, Golestan B. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J Res Med Sci 2012;17:607-14.
20. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C,Malfa L, Pineo A, Busardo A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003;24:39-52.
21. Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys 2007;458:33-9.
22. Almoznino-Sarafian D, Berman S, Mor A, Shteinshnaider M, Gorelik O, Tzur I, Alon I, Modai D, Cohen N. Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration? Eur J Nutr 2007;46:230-7.
23. Esmaillzadeh A, Samareh S, Azadbakht L. Dietary patterns among pregnant women in the west-north of Iran. Pak J Biol Sci 2008;11:793-6.
24. Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypoand hypermagnesemia in an Iranian urban population. Ann Hum Biol 2011;38:150-5.
25. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 2004;4:14.
26. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl 1):S81-90.
27. Boulet SL, Alexander GR, Salihu HM, Pass M. Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003;188:1372-8.
28. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013;36:845-53.
29. Tatsch E, Bochi GV, Pereira Rda S, Kober H, Agertt VA, de Campos MM, Gomes P, Duarte MM, Moresco RN. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 2011;44:348-50.
30. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-6.
31. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985;105:581-4.
32. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-40.
33. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician 2002;65:599-606.
34. Nobile de Santis MS, Radaelli T, Taricco E, Bertini S, Cetin I. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed. 2004;75(Suppl 1):53-5.
35. RTI International. Triangle Park (NC): RTI International. 2007 [cited 2015 Feb 22]. Available from: http://www.rti.org/rtipress
36. Ryan MP, Ryan MF, Counihan TB. The effect of diuretics on lymphocyte magnesium and potassium. Acta Med Scand Suppl 1981;647:153-61.
37. Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, Jacques PF. Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr 2006;25:486-92.
38. Guerrero-Romero F, Rodriguez-Moran M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006;22:471-6.
39. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH, Rodriguez-Moran M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance: a double-blind placebocontrolled randomized trial. Diabetes Metab 2004;30:253-8.
40. Kowluru A, Chen HQ, Modrick LM, Stefanelli C. Activation of acetyl-CoA carboxylase by a glutamate-and magnesium-sensitive protein phosphatase in the islet beta-cell. Diabetes 2001;50:1580-7.
41. Murakami M, Ishizuka J, Sumi S, Nickols GA, Cooper CW, Townsend CM Jr., Thompson JC. Role of extracellular magnesium in insulin secretion from rat insulinoma cells. Proc Soc Exp Biol Med 1992;200:490-4.
42. Lal J, Vasudev K, Kela AK, Jain SK. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India 2003;51:37-42.
43. Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res 2012;25:28-39.
44. Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:1147-52.
45. Purvis JR, Cummings DM, Landsman P, Carroll R, Barakat H, Bray J, Whitley C, Horner RD. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Fam Med 1994;3:503-8.
46. Kishimoto Y, Tani M, Uto-Kondo H, Saita E, Iizuka M, Sone H, Yokota K, Kondo K. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 2010;103:469-72.
47. Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 1986;5:507-19.
48. Nielsen FH, Johnson LK, Zeng H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res 2010; 23:158-68.
49. Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, Chang S, Chen ZK. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity. Transplant Proc 2005;37:1892-5.
50. Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A. Effect of magnesium supplementation on carotid intimamedia thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol 2013;69:309-16.
51. Aneiros E, Philipp S, Lis A, Freichel M, Cavalie A. Modulation of Ca2 + signaling by Na+/Ca2+ exchangers in mast cells. J Immunol 2005; 174:119-30.
52. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007;458:48-56.
53. Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005;28:2458-64.
54. Farvid MS, Jalali M, Siassi F, Saadat N, Hosseini M. The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr 2004;23:272-9.
55. Bede O, Nagy D, Suranyi A, Horvath I, Szlavik M, Gyurkovits K. Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children. Inflamm Res 2008;57:279-86.
56. Liu YX, Guo YM, Wang Z. Effect of magnesium on reactive oxygen species production in the thigh muscles of broiler chickens. Br Poult Sci 2007;48:84-9.
57. Boujelben M, Ghorbel F, Vincent C, Makni-Ayadi F, Guermazi F, Croute F, El-Feki A. Lipid peroxidation and HSP72/73 expression in rat following cadmium chloride administration: interactions of magnesium supplementation. Exp Toxicol Pathol 2006;57:437-43.
58. Misra PK, Kapoor RK, Dixit S, Seth TD. Trace metals in neonatal hyperbilirubinemia. Indian Pediatr 1988;25:761-4.
59. Skajaa K, Dorup I, Sandstrom BM. Magnesium intake and status and pregnancy outcome in a Danish population. Br J Obstet Gynaecol 1991;98:919-28.
60. Pintov S, Kohelet D, Arbel E, Goldberg M. Predictive inability of cord zinc, magnesium and copper levels on the development of benign hyperbilirubinemia in the newborn. Acta Paediatr 1992;81:868-9.
61. Tuncer M, Demirsoy S, Ozsoylu S, Erdem G. The significance of zinc, copper and magnesium levels of maternal, cord and newborns' sera in hyperbilirubinemia of unknown etiology. Turk J Pediatr 1982;24: 227-33.
62. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr 2008;99(Suppl 3):S24-36.
63. Carpenter TO, DeLucia MC, Zhang JH, Bejnerowicz G, Tartamella L, Dziura J, Petersen KF, Befroy D, Cohen D. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. J Clin Endocrinol Metab 2006;91: 4866-72.